Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03110809 · ClinicalTrials.gov registry record · NA
The Effects of Capsinoids on Brown Adipose Tissue Activation in Obesity
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT03110809 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 19 participants.
The verdict
NCT03110809, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
This research study is being done to determine whether taking a dietary supplement called capsinoids, derived from sweet peppers, can activate brown fat that is already present or even generate new brown fat in individuals with excess weight. Previous studies have suggested that chronic consumption of capsinoids may be able to generate new brown fat in thin individuals. Capsinoids may also have a small positive effect on metabolism (increased calorie-burning) and fat loss. The knowledge gained in this study may eventually lead to more treatment options for people with excess weight.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Capsinoid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2017-04-17 |
| Est. Completion | 2021-08-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03110809
The ClinicalTrials.gov registry entry for NCT03110809 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03110809 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03110809 about?
NCT03110809 is a clinical study titled "The Effects of Capsinoids on Brown Adipose Tissue Activation in Obesity". This research study is being done to determine whether taking a dietary supplement called capsinoids, derived from sweet peppers, can activate brown fat that is already present or even generate new brown fat in individuals with excess weight. Previous studies have suggested that chronic consumption ...
What is the current status of trial NCT03110809?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2017-04-17. Estimated completion is 2021-08-13.
What interventions are being tested in trial NCT03110809?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Capsinoid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03110809?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.